Skip to content

Clinical trials

Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Country / region: Netherlands Clear all

70 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20031
20053
20061
20071
20081
20094
20101
20111
20124
20134
20143
20152
20161
20175
20185
20193
20206
20212
20224
20236
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting13
Terminated11
Active, not recruiting3
Unknown status3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group6
Novartis Pharmaceuticals6
Princess Maxima Center for Pediatric Oncology5
Amgen4
Bristol-Myers Squibb4
European Organisation for Research and Treatment of Cancer - EORTC3
Kiadis Pharma3
Amgen Research (Munich) GmbH2
Charite University, Berlin, Germany2
Gamida Cell ltd2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma70
Leukemia21
Leukemia, Myeloid, Acute17
Recurrence10
Myelodysplastic Syndromes9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive8
Lymphoma8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma8
Neoplasms7
Burkitt Lymphoma6

Trials

Showing 26 to 50 of 70. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.